<DOC>
	<DOCNO>NCT02980965</DOCNO>
	<brief_summary>This open-label , randomize control trial aim compare efficacy safety concurrent neoadjuvant chemotherapy endocrine therapy neoadjuvant chemotherapy alone ER-positive , HER2-negative breast cancer .</brief_summary>
	<brief_title>Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone ER-positive , HER2-negative Breast Cancer</brief_title>
	<detailed_description>Data show concurrent neoadjuvant chemotherapy endocrine therapy effective option ER-positive , HER2-negative breast cancer patient . However still controversial issue . The present study open-label randomize controlled clinical trial aim investigate efficacy concurrent NCT endocrine therapy ( AI without GnRH-a ) patient ER-positive , HER2-negative breast carcinoma .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<criteria>1 . Estrogen receptorpositive HER2negative breast cancer patient , histological stage IIaIIIc . 2 . Without previous chemotherapy endocrine therapy . 3 . ECOG score 02 point 4 . With measurable evaluable breast tumor pathologically confirm invasive ductal carcinoma 5 . Age : 1870 year 6 . Lateral breast cancer 7 . Normal acceptable kidney , liver , cardiovascular , bone marrow function 1 . Pregnant woman nurse mother 2 . With distant metastasis 3 . With history malignant tumor complicate malignant tumor addition breast cancer , except nonmelanoma skin cancer , situ cervical cancer cure malignant tumor without basis recurrence least five year 4 . With mental illness condition affect patient compliance 5 . With serious disease medical condition : 1 . Congestive heart failure unstable angina pectoris , myocardial infarction within 6 month enrollment , uncontrolled hypertension uncontrolled highrisk arrhythmia consider investigator 2 . Obvious neurological psychiatric disorder , include psychosis , epileptic dementia disease may affect understand sign inform consent 3 . Uncontrolled acute infection 6 . Concurrent use investigational drug ; participate clinical trial involve investigational drug within 30 day study 7 . With allergic constitution know suspected drug allergy 8 . Not suitable trial consider investigator</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>neoadjuvant chemotherapy</keyword>
	<keyword>endocrine therapy</keyword>
	<keyword>concurrent</keyword>
</DOC>